PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 148 filers reported holding PROTHENA CORP PLC in Q1 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,478,729 | -29.3% | 445,155 | 0.0% | 0.39% | -24.9% |
Q2 2023 | $30,395,183 | +42.9% | 445,155 | +1.5% | 0.51% | +31.8% |
Q1 2023 | $21,265,340 | -19.6% | 438,732 | 0.0% | 0.39% | -25.1% |
Q4 2022 | $26,433,603 | +89.6% | 438,732 | +90.8% | 0.52% | +90.1% |
Q3 2022 | $13,945,000 | +926.9% | 230,000 | +521.6% | 0.27% | +328.1% |
Q1 2018 | $1,358,000 | -69.8% | 37,000 | -69.2% | 0.06% | -72.8% |
Q4 2017 | $4,499,000 | -42.1% | 120,000 | 0.0% | 0.24% | -46.6% |
Q3 2017 | $7,772,000 | +19.7% | 120,000 | 0.0% | 0.44% | +8.9% |
Q2 2017 | $6,494,000 | -3.0% | 120,000 | 0.0% | 0.40% | -8.8% |
Q1 2017 | $6,695,000 | +13.4% | 120,000 | 0.0% | 0.44% | +15.4% |
Q4 2016 | $5,903,000 | -18.0% | 120,000 | 0.0% | 0.38% | -12.5% |
Q3 2016 | $7,196,000 | +71.5% | 120,000 | 0.0% | 0.44% | +70.8% |
Q2 2016 | $4,195,000 | -15.1% | 120,000 | 0.0% | 0.26% | -6.9% |
Q1 2016 | $4,939,000 | -30.8% | 120,000 | +14.5% | 0.28% | -22.7% |
Q4 2015 | $7,138,000 | +80.6% | 104,800 | +20.2% | 0.36% | +55.2% |
Q3 2015 | $3,952,000 | +77.0% | 87,172 | +49.5% | 0.23% | -33.7% |
Q1 2014 | $2,233,000 | – | 58,300 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 11,284,280 | $557,443,000 | 17.76% |
Prosight Management, LP | 441,000 | $21,785,000 | 13.04% |
First Light Asset Management, LLC | 1,622,941 | $80,173,000 | 5.74% |
Palo Alto Investors LP | 1,685,282 | $83,253,000 | 5.32% |
Birchview Capital, LP | 40,247 | $1,988,000 | 1.28% |
DCF Advisers, LLC | 60,000 | $2,964,000 | 1.20% |
HighVista Strategies LLC | 28,078 | $1,387,000 | 1.10% |
APOGEM CAPITAL LLC | 33,212 | $1,641,000 | 1.08% |
Redmile Group, LLC | 765,675 | $37,824,000 | 0.86% |
Rock Springs Capital Management LP | 647,730 | $31,998,000 | 0.74% |